Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	PurePenn, LLC	Keystone Relief Centers LLC	Mountaineer Holding, LLC	Nature’s Remedy of Massachusetts, Inc.	Solevo Wellness West Virginia, LLC	Super Voting Shares	Multiple Voting Shares	Subordinate Voting Shares	Subordinate Voting Shares PurePenn, Pioneer, Solevo	Subordinate Voting Shares Mountaineer Holding, LLC	Subordinate Voting Shares Nature’s Remedy of Massachusetts, Inc.	Subordinate Voting Shares Solevo Wellness West Virginia, LLC	Common Shares	Common Shares PurePenn, Pioneer, Solevo	Common Shares Mountaineer Holding, LLC	Common Shares Nature’s Remedy of Massachusetts, Inc.	Common Shares Solevo Wellness West Virginia, LLC	Additional Paid-in-Capital	Additional Paid-in-Capital PurePenn, LLC	Additional Paid-in-Capital Keystone Relief Centers LLC	Additional Paid-in-Capital Mountaineer Holding, LLC	Additional Paid-in-Capital Nature’s Remedy of Massachusetts, Inc.	Additional Paid-in-Capital Solevo Wellness West Virginia, LLC	Accumulated Earnings	Non-Controlling Interest
Beginning Balance at Dec. 31, 2020	$ 447,904																		$ 328,214						$ 119,690
Beginning Balance (in shares) at Dec. 31, 2020							58,182,500	1,439,037	59,952,461					119,573,998
Share-based compensation	741																		741
Shares issued for cash - warrant exercise	6,861																		6,861
Shares issued for cash - warrant exercise (in shares)									469,133					469,133
Conversion of warrants to subordinate voting shares (in shares)									133,408					133,408
Conversion of Multiple Voting to Subordinate Voting Shares								(117,668)	117,668
Conversion of Super Voting Shares to Subordinate Voting Shares (in shares)							(3,021,100)		3,021,100
Conversion of Super Voting Shares to Multiple Voting Shares (in shares)							(55,161,400)	55,161,400
Net (loss) income and comprehensive income (loss)	30,078																								30,078
Ending Balance at Mar. 31, 2021	485,584																		335,816						149,768
Ending Balance (in shares) at Mar. 31, 2021								56,482,769	63,693,770					120,176,539
Beginning Balance at Dec. 31, 2020	447,904																		328,214						119,690
Beginning Balance (in shares) at Dec. 31, 2020							58,182,500	1,439,037	59,952,461					119,573,998
Net (loss) income and comprehensive income (loss)	70,958
Ending Balance at Jun. 30, 2021	756,235																		565,587						190,648
Ending Balance (in shares) at Jun. 30, 2021								56,461,096	70,521,604					126,982,700
Beginning Balance at Mar. 31, 2021	485,584																		335,816						149,768
Beginning Balance (in shares) at Mar. 31, 2021								56,482,769	63,693,770					120,176,539
Share-based compensation	744																		744
Shares issued for cash - warrant exercise	811																		811
Shares issued for cash - warrant exercise (in shares)									100,400					100,400
Common stock issued upon cashless warrant exercise (in shares)									661,614					661,614
Tax withholding related to net share settlement of equity awards	(595)																		(595)
Tax withholding related to net share settlement of equity awards (in shares)									(15,734)					(15,734)
Issuance of shares private placement, net of issuance costs	217,896																		217,896
Issuance of shares private placement, net of issuance costs (in shares)									5,750,000					5,750,000
Contingent consideration payable in shares	(2,800)																		(2,800)
Adjustment of fair value of equity consideration		$ 2,711	$ 1,004																	$ 2,711	$ 1,004
Shares issued for acquisition				$ 3,000	$ 6,500	$ 500																$ 3,000	$ 6,500	$ 500
Shares issued for acquisition (in shares)											60,342	237,881	11,658			60,342	237,881	11,658
Conversion of Multiple Voting to Subordinate Voting Shares								(21,673)	21,673
Net (loss) income and comprehensive income (loss)	40,880																								40,880
Ending Balance at Jun. 30, 2021	756,235																		565,587						190,648
Ending Balance (in shares) at Jun. 30, 2021								56,461,096	70,521,604					126,982,700
Beginning Balance at Dec. 31, 2021	2,147,373																		2,008,100						137,721	$ 1,552
Beginning Balance (in shares) at Dec. 31, 2021								51,916,999	128,587,173					180,504,172
Share-based compensation	4,564																		4,564
Exercise of stock options	108																		108
Exercise of stock options (in shares)									45,775					45,775
Shares issued for cash - warrant exercise	22																		22
Shares issued for cash - warrant exercise (in shares)									1,648					1,648
Shares issued under share compensation plans (in shares)									16,257					16,257
Tax withholding related to net share settlement of equity awards	(230)																		(230)
Tax withholding related to net share settlement of equity awards (in shares)									(10,005)					(10,005)
Conversion of Multiple Voting to Subordinate Voting Shares								(2,699,100)	2,699,100
Shares issued for PurePenn, Pioneer, and Solevo earnouts (in shares)										3,626,295					3,626,295
Distribution	(50)																									(50)
Divestment of variable interest entity	(111)																									(111)
Net (loss) income and comprehensive income (loss)	(32,482)																								(31,975)	(507)
Ending Balance at Mar. 31, 2022	2,119,194																		2,012,564						105,746	884
Ending Balance (in shares) at Mar. 31, 2022								49,217,899	134,966,243					184,184,142
Beginning Balance at Dec. 31, 2021	$ 2,147,373																		2,008,100						137,721	1,552
Beginning Balance (in shares) at Dec. 31, 2021								51,916,999	128,587,173					180,504,172
Exercise of stock options (in shares)	92,811
Net (loss) income and comprehensive income (loss)	$ (56,503)
Ending Balance at Jun. 30, 2022	2,120,092																		2,037,483						83,255	(646)
Ending Balance (in shares) at Jun. 30, 2022								36,126,099	149,512,098					185,638,197
Beginning Balance at Mar. 31, 2022	2,119,194																		2,012,564						105,746	884
Beginning Balance (in shares) at Mar. 31, 2022								49,217,899	134,966,243					184,184,142
Share-based compensation	5,703																		5,703
Exercise of stock options (in shares)									2,997					2,997
Shares issued for cash - warrant exercise	19,216																		19,216
Shares issued for cash - warrant exercise (in shares)									1,426,614					1,426,614
Subordinate Voting Shares issued under share compensation plans (in shares)									24,444					24,444
Conversion of Multiple Voting to Subordinate Voting Shares								(13,091,800)	13,091,800
Net (loss) income and comprehensive income (loss)	(24,021)																								(22,491)	(1,530)
Ending Balance at Jun. 30, 2022	$ 2,120,092																		$ 2,037,483						$ 83,255	$ (646)
Ending Balance (in shares) at Jun. 30, 2022								36,126,099	149,512,098					185,638,197